Drug CombinationsDrug SynergismDrug Therapy, CombinationDrug InteractionsAntineoplastic Combined Chemotherapy ProtocolsProguanilMethenamineAntineoplastic AgentsAntimalarialsDapsoneDrug TherapyArtemisininsCell Line, TumorDrug Screening Assays, AntitumorAtovaquoneDose-Response Relationship, DrugDrug Administration ScheduleDrug AntagonismMethylthioinosineCyclopentolateTropicamideCellophaneDrug ResistanceSulfamethoxazoleTreatment OutcomePyrimethamineMefloquineDrug Evaluation, PreclinicalPharmaceutical PreparationsTime FactorsCisplatinInhibitory Concentration 50Cell SurvivalPyrazinesFloxuridineSulfadoxineRifampinMicrobial Sensitivity TestsDoxorubicinFluorouracilXenograft Model Antitumor AssaysMolecular Targeted TherapyNeoplasmsNanoconjugatesAmodiaquineAdministration, OralAmikacinChloroquineSesquiterpenesApoptosisBoronic AcidsAntifungal AgentsPiperazinesPyrimidinesPhentermineNaphthoquinonesDeoxycytidineDrug-Related Side Effects and Adverse ReactionsNiacinamideDrug Resistance, NeoplasmQuinolinesAnti-Bacterial AgentsFluorenesAntitubercular AgentsDrug EvaluationPaclitaxelPlasmodium falciparumVincristineAmphotericin BClinical Trials as TopicTrimethoprimCytarabineRadiation DosageDrug DesignAnti-HIV AgentsLethal Dose 50Clinical Trials, Phase I as TopicPhenylurea CompoundsPharmacologySystems BiologyNitroimidazolesQuinazolinesModels, BiologicalMalaria, FalciparumMedetomidineArea Under CurveAntihypertensive AgentsAntimetabolites, AntineoplasticParasitic Sensitivity TestsAntiprotozoal AgentsMethotrexateMice, NudePiperidinesPyridinesDrug Resistance, MultipleCyclophosphamideBenzenesulfonatesDisease Models, AnimalCell ProliferationTriazines